Immunicom Announces Promising Preliminary Data from its Immunopheresis® Study in Late-Stage Cancer and Metastatic Melanoma Patients Presented at 2021 SITC Congress
Immunicom’s highly selective extracorporeal blood-filtering column shown to be safe and well-tolerated in treating late-stage cancer patients who fail multiple...